Form 4: Chime Financial GC Exercises Options, Sells Shares
Insider Transaction Report
Chime Financial's General Counsel, Adam B. Frankel, reported the exercise of stock options and a subsequent sale of Class A Common Stock under a pre-arranged 10b5-1 trading plan.
Summary
- Adam B. Frankel, General Counsel of Chime Financial, Inc., reported transactions on January 9, 2026.
- Exercised employee stock options to acquire 500 shares of Class A Common Stock at a price of $16.56 per share.
- Simultaneously sold 500 shares of Class A Common Stock at a price of $28.00 per share.
- The sale was conducted under a Rule 10b5-1 trading plan adopted on September 8, 2025.
- Following these transactions, Frankel beneficially owns 218,849 shares of Class A Common Stock and 273,567 derivative securities (employee stock options).
- Certain beneficially owned securities are Restricted Stock Units (RSUs) subject to applicable vesting schedules and conditions.
- The employee stock option exercised had 1/4th of its shares vested on August 8, 2024, with 1/48th vesting monthly thereafter, subject to continued service.
Sentiment
Score: 5
Explanation: The sentiment is neutral. While an insider sale occurred, it was part of a pre-planned 10b5-1 trading plan, which mitigates any negative signal. The exercise of options also indicates the executive is realizing value from their compensation.
Positives
- The transactions demonstrate an insider exercising vested options, indicating value in the company's stock.
- The sale was executed at a higher price ($28.00) than the exercise price ($16.56), indicating a profit for the insider.
Negatives
- An insider sale, even if pre-planned, can sometimes be perceived as a slight negative signal, though the amount is small relative to total holdings.
Industry Context
This is a routine insider transaction filing (Form 4) for Chime Financial, Inc., reflecting an executive's exercise of stock options and subsequent sale of shares. Such transactions are common in the financial technology (fintech) industry as executives manage their equity compensation.
Stakeholder Impact
- Shareholders: The sale of a small number of shares by an executive under a 10b5-1 plan is unlikely to have a significant direct impact on shareholders, but provides transparency into executive compensation management.
Key Dates
| Date | Description |
|---|---|
| 08/08/2024 | Vesting date for 1/4th of shares subject to the employee stock option. |
| 09/08/2025 | Date Rule 10b5-1 trading plan was adopted by the Reporting Person. |
| 01/09/2026 | Date of stock option exercise and subsequent sale of Class A Common Stock. |
| 01/13/2026 | Signature date of the filing. |
| 08/31/2033 | Expiration date of the employee stock option. |
Recommendation
holdThis Form 4 filing details a routine insider transaction where the General Counsel exercised stock options and immediately sold an equivalent number of shares under a pre-arranged 10b5-1 plan. This type of transaction is common for executives managing their equity compensation and does not typically signal a change in the company's fundamental outlook or performance. The small volume of shares sold relative to the executive's total holdings further supports a neutral interpretation. Therefore, based solely on this filing, a 'hold' recommendation is appropriate as there is no new information to warrant a change in investment thesis.
Keywords
Chime Financial, CHYM, Form 4, Insider Trading, Stock Option Exercise, Stock Sale, 10b5-1 Plan, Adam B. Frankel, General Counsel, Equity Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.